Drugs / FE 204205
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02929407 | Nov 2016 → Sep 2017 | portal hypertension | Ferring Pharmaceuticals | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FE 204205 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02929407 ↗ |
| Route | Intravenous | “increasing IV doses of FE 204205” NCT02929407 ↗ |